In normal men, free fatty acids reduce peripheral but not splanchnic glucose uptake.
Raising plasma free fatty acid (FFA) levels reduces muscle glucose uptake, but the effect of FFAs on splanchnic glucose uptake, total glucose output, and glucose cycling may also be critical to producing lipid-induced glucose intolerance. In eight normal volunteers, we measured glucose turnover and cycling rates ([2H7]glucose infusion) during a moderately hyperglycemic (7.7 mmol/l) hyperinsulinemic clamp, before and after ingestion of a labeled (dideuterated) oral glucose load (700 mg/kg). Each test was performed twice, with either a lipid or a saline infusion; four subjects also had a third test with a glycerol infusion. As shown by similar rates of exogenous glucose appearance, the lipid infusion did not reduce first-pass splanchnic glucose uptake (saline 1.48+/-0.18, lipid 1.69+/-0.17, and glycerol 1.88+/-0.17 mmol/kg per 180 min; NS), but it reduced peripheral glucose uptake by 40% (P < 0.01 vs. both saline and glycerol infusions). Before oral ingestion of glucose, total glucose output was similarly increased by the lipid and glycerol infusions. Total glucose output was significantly increased by FFAs after oral ingestion of glucose (saline 3.68+/-1.15, glycerol 3.68+/-1.70, and lipid 7.92+/-0.88 micromol x kg(-1) x min(-1); P < 0.01 vs. saline and P < 0.05 vs. glycerol). The glucose cycling rate was approximately 2.7 micromol x kg(-1) x min(-1) with the three infusions and tended to decrease all along the lipid infusion, which argues against a stimulation of glucose-6-phosphatase by FFAs. It is concluded that in situations of moderate hyperinsulinemia-hyperglycemia, FFAs reduce peripheral but not splanchnic glucose uptake. Total glucose output is increased by FFAs, by a mechanism that does not seem to involve stimulation of glucose-6-phosphatase.
Rigalleau
V
V
Institut de Physiologie, Lausanne, Switzerland. vincent.rigalleau@iphysiol.unil.ch
Binnert
C
C
Minehira
K
K
Stefanoni
N
N
Schneiter
P
P
Henchoz
E
E
Matzinger
O
O
Cayeux
C
C
Jéquier
E
E
Tappy
L
L
D000328:Adult; D005223:Fats / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood* / Q000494:pharmacology; D005947:Glucose / Q000493:pharmacokinetics*; D005990:Glycerol / Q000494:pharmacology; D006728:Hormones / Q000097:blood; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism*; D012016:Reference Values; D014018:Tissue Distribution; D014781:Viscera / Q000378:metabolism*
D005223:Fats; D005230:Fatty Acids, Nonesterified; D006728:Hormones; D005947:Glucose; D005990:Glycerol